ATE141050T1 - Zusammensetzung zur behandlung steroid- induzierter hautatrophie enthaltend ein salz einer c3-7 alpha-hydroxy-carbonsäure - Google Patents

Zusammensetzung zur behandlung steroid- induzierter hautatrophie enthaltend ein salz einer c3-7 alpha-hydroxy-carbonsäure

Info

Publication number
ATE141050T1
ATE141050T1 AT92104725T AT92104725T ATE141050T1 AT E141050 T1 ATE141050 T1 AT E141050T1 AT 92104725 T AT92104725 T AT 92104725T AT 92104725 T AT92104725 T AT 92104725T AT E141050 T1 ATE141050 T1 AT E141050T1
Authority
AT
Austria
Prior art keywords
alpha
steroid
hydroxy
salt
treatment
Prior art date
Application number
AT92104725T
Other languages
English (en)
Inventor
Prakash Parab
Robert Lavker
James Leyden
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE141050T1 publication Critical patent/ATE141050T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AT92104725T 1991-03-19 1992-03-18 Zusammensetzung zur behandlung steroid- induzierter hautatrophie enthaltend ein salz einer c3-7 alpha-hydroxy-carbonsäure ATE141050T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67157791A 1991-03-19 1991-03-19

Publications (1)

Publication Number Publication Date
ATE141050T1 true ATE141050T1 (de) 1996-08-15

Family

ID=24695083

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92104725T ATE141050T1 (de) 1991-03-19 1992-03-18 Zusammensetzung zur behandlung steroid- induzierter hautatrophie enthaltend ein salz einer c3-7 alpha-hydroxy-carbonsäure

Country Status (15)

Country Link
US (2) US5254343A (de)
EP (1) EP0504862B1 (de)
JP (1) JP3504279B2 (de)
KR (1) KR100193993B1 (de)
AT (1) ATE141050T1 (de)
AU (1) AU655005B2 (de)
CA (1) CA2063127C (de)
DE (1) DE69212610T2 (de)
DK (1) DK0504862T3 (de)
ES (1) ES2090390T3 (de)
GR (1) GR3020779T3 (de)
IE (1) IE920859A1 (de)
SG (2) SG141206A1 (de)
TW (1) TW208658B (de)
ZA (1) ZA921821B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254343A (en) * 1991-03-19 1993-10-19 Bristol-Myers Squibb Company Reduction of cutaneous atrophy
US5420106A (en) * 1994-03-22 1995-05-30 Bristol-Myers Squibb Company Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
CA2143515A1 (en) * 1994-03-22 1995-09-23 Prakash Parab Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
US5683705A (en) * 1996-03-29 1997-11-04 Estee Lauder, Inc. Sulfur-based amides and bis-amides useful against skin disorders
US5993792A (en) * 1997-11-13 1999-11-30 Tiro Industries Incorporated System for customized hair products containing surfactants
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
AU2002244247B2 (en) 2001-03-01 2007-12-13 Harbor Biosciences, Inc. Use of certain steroids for treatment of blood cell deficiencies
US20030017181A1 (en) 2001-05-31 2003-01-23 Rood Gloria A. Dermatological compositions and methods
US20040138187A1 (en) 2002-08-28 2004-07-15 Reading Christopher L. Therapeutic treatment methods
AU2005330504B2 (en) 2004-09-29 2010-10-28 Harbor Biosciences, Inc. Steroid analogs and characterization and treatment methods
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
DE102014209988A1 (de) * 2014-05-26 2015-11-26 Deb Ip Limited Aluminiumlactat als Hautschutzkomponente

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US4380549A (en) * 1975-07-23 1983-04-19 Scott Eugene J Van Topical treatment of dry skin
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
BE858404A (fr) * 1976-09-07 1978-03-06 Scott Eugene J Van Traitement de l'affection dermatologique dite "peau seche"
US4246261A (en) * 1979-08-09 1981-01-20 Scott Eugene J Van Additives enhancing topical corticosteroid action
US4485091A (en) * 1980-07-15 1984-11-27 Quinoderm Limited Dermatological compositions
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US4937068A (en) * 1988-10-31 1990-06-26 Jim Baral Sun tanning medication and treatment
US5254343A (en) * 1991-03-19 1993-10-19 Bristol-Myers Squibb Company Reduction of cutaneous atrophy

Also Published As

Publication number Publication date
SG141206A1 (en) 2008-04-28
DE69212610T2 (de) 1997-03-27
HK1004532A1 (en) 1998-11-27
JPH05117144A (ja) 1993-05-14
DE69212610D1 (de) 1996-09-12
IE920859A1 (en) 1992-09-23
DK0504862T3 (da) 1996-09-02
US5807600A (en) 1998-09-15
EP0504862A1 (de) 1992-09-23
EP0504862B1 (de) 1996-08-07
ES2090390T3 (es) 1996-10-16
CA2063127A1 (en) 1992-09-20
TW208658B (de) 1993-07-01
ZA921821B (en) 1993-01-27
KR920017648A (ko) 1992-10-21
CA2063127C (en) 2002-01-29
JP3504279B2 (ja) 2004-03-08
AU1295592A (en) 1992-09-24
SG79901A1 (en) 2001-04-17
US5254343A (en) 1993-10-19
KR100193993B1 (ko) 1999-06-15
AU655005B2 (en) 1994-12-01
GR3020779T3 (en) 1996-11-30

Similar Documents

Publication Publication Date Title
DE69212610D1 (de) Zusammensetzung zur Behandlung Steroid-induzierter Hautatrophie enthaltend ein Salz einer C3-7 Alpha-Hydroxy-Carbonsäure
DK393288D0 (da) Praeparat til saarheling og knogleregenerering
DE10075006I1 (de) Verwendung von (s)(+)-2-aethoxy-4- N- 1-(2piperidino-phenyl)-3-methyl-1-butyl aminocarbonylmethyl-Benzoesaeure zur Herstellung eines Langzeitantidiabetikums
DE69221501D1 (de) Verfahren zum vermindern von durch medizinische vorrichtungen bedingten infektionen
UY26256A1 (es) Amidas de ácidos carboxílicos, medicamentos que contienen estos compuestos, su utilización y su preparación
DK0479799T3 (da) Sårheling
ATE109350T1 (de) Verwendung von ofloxacin oder dessen salzen zur herstellung eines lokalpräparats für die behandlung von otopathie.
IT1264563B1 (it) Composti fotocromatici e metodo per la loro preparazione
PL329413A1 (en) Chemical compounds exhibiting properties capable to cause growth hormone release
DE69507843D1 (de) Dermatologische Zusammensetzung enthaltend Milchsäuresalze
DK472387D0 (da) Naphthalin- og indanderivater samt laegemidler med indhold af saadanne forbindelser
ES2172549T3 (es) Nuevas sales por adicion de acidos de cefem, cristalinas, y procedimiento para su preparacion.
LU79376A1 (de) 1,2,3-thiadiazol-3-in-5-yliden-harnstoffe,verfahren zur herstellung dieser verbindungen sowie diese enthaltende mittel mit wachstumsregulatorischer wirkung
DE69322353D1 (de) Chromen-Derivate mit einer Trien-Kette zur Verwendung bei der Behandlung der Osteoporose und der entzündlichen Erkrankungen
DE3766619D1 (de) Verwendung von dicarbonsaeuren mit 7-13 kohlenstoffatomen oder physiologisch vertraeglichen salzen davon zur herstellung eines arzneimittels zur topischen behandlung von rosazea.
DE68907386D1 (de) Verwendung von phytinsaeure oder deren salzen zur verhinderung oder behandlung von lebererkrankungen.
ATE61573T1 (de) Neue kristalline salze von aryloxypropanolaminen, verfahren zu ihrer herstellung und ihre verwendung.
DE69131058D1 (de) Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis
DE60018647D1 (de) Verwendung von 4,6-Dimethoxy-Indol 2-Carbonsäure oder Derivaten davon zur Seborrhea Behandlung
BG45853A3 (bg) Метод за получаване на бензамидни съединения
DE3671216D1 (de) Verfahren zur herstellung von trifluordichlorethyl substituierten saeuren und zinkverbindungen.
ATE113582T1 (de) Verfahren zur oxidation von hydroxymethylpyridinderivaten zu pyridincarbonsäurederivaten.
JPS5417183A (en) Preparation of l-glutamic acid
DE3669508D1 (de) Verbrueckungsreagenz, verfahren zu seiner herstellung und seine anwendung.
DE69529070D1 (de) Verwendung von 5,6-o-benzyliden-l-ascorbinsäure oder deren salze zur herstellung eines medikaments zur behandlung von hiv

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee